Upper gastrointestinal cancer in Ardabil, North-West of Iran: A review [Internet]. [cited 2023 Nov 5]. Available from: https://www.researchgate.net/publication/242301430_Upper_gastrointestinal_cancer_in_Ardabil_North-West_of_Iran_A_review
Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. J Cancer [Internet]. 1999;80:827–41.
Milano AF. 20-Year comparative survival and mortality of cancer of the stomach by age, sex, race, stage, grade, cohort entry time-period, disease duration & selected ICD-O-3 oncologic phenotypes: a systematic review of 157,258 cases for diagnosis years 1973-2014: (SEER*Stat 8.3.4). J Insur Med. 2019;48(1):5–23.
Fuchs CS, Giovannucci EL, Colditz GA, Hunter DJ, Speizer FE, Willett WC. A prospective study of family history and the risk of colorectal cancer. New England J Med. 1994;331(25):1669–74.
How should we follow up colorectal premalignant conditions? Colorectal Cancer in Clinical Practice [Internet]. 2001 77–86. Available from: https://www.taylorfrancis.com/chapters/edit/https://doi.org/10.3109/9780203214275-9/follow-colorectal-premalignant-conditions-bernard-levin-paul-rozen-graeme-young
Smith RA, von Eschenbach AC, Wender R, Levin B, Byers T, Rothenberger D, et al. American cancer society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers: ALSO: update 2001–testing for early lung cancer detection. CA Cancer J Clin. 2001;51(1):38–75.
Article CAS PubMed Google Scholar
Joseph DA, King JB, Dowling NF, Thomas CC, Richardson LC. Vital signs: colorectal cancer screening test use — United States. Morb Mortal Wkly Rep. 2020;69:253–9.
Joseph DA, Degroff AS, Hayes NS, Wong FL, Plescia M. The colorectal cancer control program: partnering to increase population level screening. GastrointestEndosc [Internet]. 2011;73(3):429–34.
Levin B, Lieberman DA, McFarland B, Smith RA, Brooks D, Andrews KS, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American cancer society, the US multi-society task force on colorectal cancer, and the American college of radiology. CA Cancer J Clin. 2008;58(3):130–60.
Siegel R, DeSantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):104–17.
Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, Davis EM, et al. Screening for colorectal cancer: US preventive services task force recommendation statement. JAMA [Internet]. 2021;325(19):1965–77.
Rex DK, Johnson DA, Anderson JC, Schoenfeld PS, Burke CA, Inadomi JM. American college of gastroenterology guidelines for colorectal cancer screening 2008. Am J Gastroenterol [Internet]. 2009;104(3):739–50.
Taylor DP, Burt RW, Williams MS, Haug PJ, Cannon-Albright LA. Population-based family history-specific risks for colorectal cancer: a constellation approach. Gastroenterology. 2010;138(3):877–85.
Sandhu MS, Luben R, Khaw KT. Prevalence and family history of colorectal cancer: implications for screening. J Med Screen [Internet]. 2001;8(2):69–72.
Article CAS PubMed Google Scholar
Nelson CL, Sellers TA, Rich SS, Potter JD, McGovern PG, Kushi LH. Familial clustering of colon, breast, uterine, and ovarian cancers as assessed by family history. Genet Epidemiol [Internet]. 1993;10(4):235–44.
Article CAS PubMed Google Scholar
Le Marchand L, Ping Zhao L, Quiaoit F, Wilkens LR, Kolonel LN. Family history and risk of colorectal cancer in the multiethnic population of Hawaii. Am J Epidemiol. 1996;144(12):1122–8.
Slattery ML, Kerber RA. Family history of cancer and colon cancer risk: the Utah population database. JNCI: J National Cancer Inst [Internet]. 1994;86(21):1618–26. https://doi.org/10.1093/jnci/86.21.1618.
Butterworth AS, Higgins JPT, Pharoah P. Relative and absolute risk of colorectal cancer for individuals with a family history: A meta-analysis. Eur J Cancer [Internet]. 2006;42(2):216–27.
Johns LE, Houlston RS. A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol. 2001;96(10):2992–3003.
Article CAS PubMed Google Scholar
Goel A, Xicola RM, Nguyen TP, Doyle BJ, Sohn VR, Bandipalliam P, et al. Aberrant DNA methylation in hereditary non-polyposis colorectal cancer without mismatch repair deficiency. Gastroenterology. 2010;138(5):1854–62.
Article CAS PubMed Google Scholar
Cordaux R, Batzer MA. The impact of retrotransposons on human genome evolution. Nat Rev Genet [Internet]. 2009;10(10):691.
Article CAS PubMed PubMed Central Google Scholar
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
Arnold M, Abnet CC, Neale RE, Vignat J, Giovannucci EL, McGlynn KA, et al. Global burden of 5 major types of gastrointestinal cancer. Gastroenterology [Internet]. 2020;159(1):335.
Article PubMed PubMed Central Google Scholar
Townsend JS, Steele CB, Richardson LC, Stewart SL. Health behaviors and cancer screening among Californians with a family history of cancer. Genet Med. 2013;15(3):212–21.
Taylor DP, Cannon-Albright LA, Sweeney C, Williams MS, Haug PJ, Mitchell JA, et al. Comparison of compliance for colorectal cancer screening and surveillance by colonoscopy based on risk. Genet Med [Internet]. 2011;13(8):737–43.
Tsai MH, Xirasagar S, Li YJ, De Groen PC. Colonoscopy screening among US adults aged 40 or older with a family history of colorectal cancer. Prevent Chronic Dis. 2015. https://doi.org/10.5888/pcd12.140533.
Cottet V, Pariente A, Nalet B, Lafon J, Milan C, Olschwang S, et al. Colonoscopic screening of first-degree relatives of patients with large adenomas: increased risk of colorectal tumors. Gastroenterology [Internet]. 2007;133(4):1086–92.
Su T, Bao Z, Zhang QY, Smith TJ, Hong JY, Ding X. Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res. 2000;60(18):5074–9.
Cheng XY, Chen GL, Zhang WX, Zhou G, Wang D, Zhou HH. Arg257Cys polymorphism of CYP2A13 in a Chinese population. ClinicaChimica Acta. 2004;343(1–2):213–6.
Khan A, Jahan F, Zahoor M, Ullah R, Albadrani GM, Mohamed HRH, et al. Association of genetic polymorphism of glutathione S-transferases with colorectal cancer susceptibility in snuff (Naswar) addicts. Brazilian J Biol [Internet]. 2022;84:e261509.
Ateş NA, Tamer L, Ateş C, Ercan B, Elipek T, Öcal K, Çamdeviren H. Glutathione S-transferase M1, T1, P1 genotypes and risk for development of colorectal cancer. Biochem Genet. 2005;43:149–63.
Huang K, Sandler RS, Millikan RC, Schroeder JC, North KE, Hu J. GSTM1 and GSTT1 polymorphisms, cigarette smoking, and risk of colon cancer: A population-based case-control study in North Carolina (United States). Cancer Causes and Control [Internet]. 2006;17(4):385–94. https://doi.org/10.1007/s10552-005-0424-1.
Katoh T, Nagata N, Kuroda Y, Itoh H, Kawahara A, Kuroki N, et al. Glutathione S-transferase Ml (GSTM1) and Tl (GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma. Carcinogenesis [Internet]. 1996;17(9):1855–9.
Article CAS PubMed Google Scholar
Little J, Sharp L, Masson LF, Brockton NT, Cotton SC, Haites NE, et al. Colorectal cancer and genetic polymorphisms of CYP1A1, GSTM1 and GSTT1: a case-control study in the Grampian region of Scotland. Int J Cancer. 2006;119(9):2155–64.
Article CAS PubMed Google Scholar
Bowel cancer incidence statistics | Cancer Research UK [Internet]. [cited 2023 Nov 5]. Available from: https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/bowel-cancer/incidence
Scheuner MT, Mcneel TS, Freedman AN. Population prevalence of familial cancer and common hereditary cancer syndromes the 2005 California health interview survey. Genet Med. 2010;12(11):726–35.
Comments (0)